Securities code: 300677 securities abbreviation: Intco Medical Technology Co.Ltd(300677) Announcement No.: 2022-011 Intco Medical Technology Co.Ltd(300677)
Announcement on the general election of the board of directors
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
The term of office of the second board of directors of Intco Medical Technology Co.Ltd(300677) (hereinafter referred to as “the company”) has expired on October 16, 2021. In accordance with the company law, the securities law, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM and other laws and regulations The election of the board of directors shall be conducted in accordance with the provisions of the articles of association and the relevant legal documents of the company.
The company held the 55th meeting of the second board of directors on February 23, 2022, deliberated and approved the proposal on the change of the board of directors and the nomination of candidates for non independent directors of the third board of directors, the proposal on the change of the board of directors and the nomination of candidates for independent directors of the third board of directors, and agreed to nominate Mr. Liu Fangyi, Ms. Sun Jing, Ms. Chen Qiong Mr. Yu Haisheng is a non independent director candidate of the third board of directors of the company and agrees to nominate Mr. Wang Yang, Mr. Wu Xiaohui and Ms. Xiang Jing as independent director candidates (please refer to the appendix for the resume of the above candidates). The nomination committee of the board of directors of the company has examined and approved the qualifications of the above-mentioned candidates for directors. The above-mentioned candidates are qualified to serve as directors of listed companies and meet the requirements of the company law, the articles of association and other provisions.
The current independent directors of the company have expressed their independent opinions on the general election of the board of directors and the nomination of candidates for directors. For details, see the company’s website on cninfo.com.cn on the same day Independent opinions of independent directors on relevant proposals of the 55th meeting of the second board of directors disclosed.
According to the provisions of the company law and the articles of association, the above director candidates shall be submitted to the first extraordinary general meeting of the company in 2022 for deliberation, and four non independent directors and three independent directors shall be elected by cumulative voting system to jointly form the third board of directors of the company. The total number of directors concurrently serving as senior managers of the company in the third board of directors of the company shall not exceed half of the total number of directors of the company, and the proportion of independent directors shall meet the requirements of relevant laws and regulations. Independent director candidates Mr. Wang Yang and Ms. Xiang Jing have obtained the qualification certificate of independent director. Mr. Wu Xiaohui promises to participate in the latest independent director training and obtain the qualification certificate of independent director recognized by Shenzhen Stock Exchange. The qualification and independence of independent director candidates shall be reported to Shenzhen stock exchange for filing and approval. After there is no objection, they can be submitted to the general meeting of shareholders for deliberation, and the cumulative voting system shall be adopted for item by item voting.
Mr. Ma Yushen, Mr. Wei Xuejun and Mr. Wei Zhixun, independent directors of the second board of directors of the company, will no longer serve as directors of the company at the expiration of their terms of office. The company expresses its heartfelt thanks to Mr. Ma Yushen, Mr. Wei Xuejun and Mr. Wei Zhixun for their contributions to the development of the company during their term of office.
The term of office of the third board of directors of the company shall be three years from the date of deliberation and approval of the first extraordinary general meeting of shareholders in 2022. In order to ensure the normal operation of the board of directors, before the election of the new board of directors by the general meeting of shareholders, the directors of the second board of directors of the company still faithfully and diligently perform their duties and responsibilities in accordance with the provisions of relevant laws, administrative regulations, normative documents and the articles of association, and will not automatically resign until the date of election of the new board of directors.
It is hereby announced.
Intco Medical Technology Co.Ltd(300677) board of directors
February 23, 2022
1、 Resume of non independent director candidates
Liu Fangyi, male, Chinese nationality, permanent residency in the United States, born in 1970. He is currently the chairman of the company and the actual controller of the company. During his study in the United States in the 1990s, Liu Fangyi began trading disposable gloves in North America. Later, he returned home for investment and gradually entered the field of medical device manufacturing. In 2016, he was selected as the leading talent in Shanghai recognized by the Organization Department of the CPC Shanghai Municipal Committee and the Shanghai human resources and Social Security Bureau; In 2017, it was selected into the list of scientific and technological innovation and entrepreneurship talents of the Ministry of science and technology. He has been the chairman of the company since July 2009.
As of the disclosure date of this announcement, Mr. Liu Fangyi directly held 192684673 shares of the company, accounting for 35.06% of the total share capital of the company. Mr. Liu Fangyi and Ms. Sun Jing, the director, are husband and wife, have no relationship with other shareholders holding more than 5% of the company’s shares, other directors, supervisors and senior managers of the company, and have not been punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that the company is not allowed to serve as a director of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances listed as dishonest Executees.
Sun Jing, female, Chinese nationality, without permanent residency abroad, was born in 1976 with an MBA degree. From March 2002 to September 2004, he served as the director of China Affairs of the world Wheelchair Foundation; From October 2004 to September 2012, served as the sales manager of Shanghai Lvlin import and Export Co., Ltd; From September 2012 to April 2015, served as the general manager of the company; He has been a director of the company since April 2015.
As of the disclosure date of this announcement, Ms. Sun Jing did not hold shares in the company and was married to Mr. Liu Fangyi, the actual controller of the company. Ms. Sun Jing has no relationship with other directors, supervisors and senior managers of the company, and has not been punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that the company is not allowed to serve as a director of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances listed as dishonest Executees.
Chen Qiong, female, Chinese nationality, without permanent residency abroad, was born in 1982 with a bachelor’s degree. From July 2004 to May 2007, served as the sales director of Shanghai Lvlin import and Export Co., Ltd; From May 2007 to August 2009, served as the manager of the comprehensive product department of Shanghai Lvlin import and Export Co., Ltd; From August 2009 to December 2014, he served as the general manager of Shanghai Lvlin import and Export Co., Ltd; He worked in the company in January 2015 and has been a director and general manager of the company since April 2015.
As of the disclosure date of this announcement, Ms. Chen Qiong directly held 387000 shares of the company, accounting for 0.07% of the total share capital of the company.
Ms. Chen Qiong has no relationship with shareholders holding more than 5% of the company’s shares, actual controllers, other directors, supervisors and senior managers of the company, and has not been punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that the company is not allowed to serve as a director of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances listed as dishonest Executees.
Yu Haisheng, male, Chinese nationality, without permanent residency abroad, was born in 1976 with a college degree. From August 1997 to May 2003, served as the marketing specialist of the Development Department of Shandong Wanxiang Electric Group Co., Ltd; From June 2003 to April 2007, he served as the business manager of Zibo Borui plastic products Co., Ltd; From June 2007 to September 2009, served as the manager of import and Export Department of Zibo Yingke frame industry Co., Ltd; From September 2009 to now, he has served as the deputy general manager of the company. As of the disclosure date of this announcement, Mr. Yu Haisheng directly held 218700 shares of the company, accounting for 0.04% of the total share capital of the company. Mr. Yu Haisheng has no relationship with shareholders holding more than 5% of the company’s shares, actual controllers, other directors, supervisors and senior managers of the company, and has not been punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that the company is not allowed to serve as a director of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances listed as dishonest Executees. 2、 Resume of independent director candidates
Wang Yang, male, Chinese nationality, without permanent residency abroad, was born in 1979 with a doctor’s degree. In 2008, he received a doctorate in accounting from Wuhan University. From July 2008 to September 2009, he served as senior manager of Investment Banking Department of Ping An Securities; From September 2009 to may 2013, he successively served as postdoctoral and senior manager of the Research Institute of Shenzhen Stock Exchange; From May 2013 to July 2014, he served as the senior manager of national small and medium-sized enterprise share transfer system Co., Ltd; From July 2014 to August 2017, he served as the director of Beijing Centergate Technologies (Holding) Co.Ltd(000931) innovative and entrepreneurial enterprise listing and cultivation base of Shenzhen Stock Exchange and the Deputy General Manager (temporary position) of Beijing Equity Trading Center; From January 2018 to now, risk control director and compliance risk control director of Beijing Zhiming Haojin Investment Management Co., Ltd.
As of the disclosure date of this announcement, Mr. Wang Yang did not hold shares of the company. Mr. Wang Yang has no relationship with the controlling shareholder, actual controller and other shareholders holding more than 5% of the voting shares of the company, other directors, supervisors and senior managers, and has not been punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that the company is not allowed to serve as a director of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances listed as dishonest Executees.
Wu Xiaohui, male, Chinese nationality, without overseas permanent residency, born in 1971, bachelor’s degree, certified public accountant. He received a bachelor’s degree from Shanghai University of technology in 1993 and served as the audit manager of Deloitte Huayong certified public accountants Co., Ltd. from April 1994 to January 1999; From February 1999 to December 1999, served as the chief financial officer of Asia Pacific Wanqi Mould Manufacturing Co., Ltd; From January 2000 to May 2004, he served as the senior audit manager of Deloitte Touche Tohmatsu (special general partnership); From June 2004 to July 2021, he served as the audit partner of Deloitte Huayong Certified Public Accountants (special general partnership) and the managing partner of Deloitte’s national A-share market; From August 2021 to now, he has been the senior partner of Zhonghui Certified Public Accountants (special general partnership) and the leading partner of national brand market; Served as a member of the 10th listing committee of Shenzhen Stock Exchange. As of the disclosure date of this announcement, Mr. Wu Xiaohui did not hold shares of the company. Mr. Wu Xiaohui has no relationship with the controlling shareholder, actual controller and other shareholders holding more than 5% of the voting shares of the company, other directors, supervisors and senior managers, and has not been punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that the company is not allowed to serve as a director of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances listed as dishonest Executees.
Xiang Jing, female, Chinese nationality, without permanent residency abroad, born in 1976, holds a doctorate and is a senior economist. In 2006, he received a doctorate from Southwest Jiaotong University; From 1995 to 1997, he successively served as the director of futures broker and customer department of Guangzhou Huaxin commodity futures company; From 1997 to 2009, he successively served as the staff of the sales department, the manager of the investment department, the director of the general manager’s office and the Secretary of the board of directors of Guangdong Guangyang High Tech Co., Ltd; From 2009 to 2010, he served as a researcher of Boda Hengtong investment consulting (Shenzhen) Co., Ltd; From 2010 to 2016, he successively served as senior investment manager and deputy director of Research Department of Shenzhen hehuixinda Investment Co., Ltd; From 2016 to 2017, he served as the director and general manager of Shenzhen hongtiancheng Fund Management Co., Ltd; From 2017 to 2020, he served as deputy general manager and Secretary of the board of directors of Shenzhen Huawei Century Technology Co., Ltd. and deputy general manager and Secretary of the board of directors of Shenzhen CLP smart information security technology Co., Ltd; Since 2017, he has served as executive director and general manager of Shenzhen Tuozhi Technology Co., Ltd; Since December 2020, he has served as an independent director of Shenzhen Haobo Window Control Technology Co., Ltd; From January 2021 to now, he has served as Hunan Jiudian Pharmaceutical Co.Ltd(300705) independent director; He has been an independent director of Shenzhen Batian Ecotypic Engineering Co.Ltd(002170) since February 2021.
As of the disclosure date of this announcement, Ms. Xiang Jing did not hold shares in the company. Ms. Xiang Jing has no relationship with the controlling shareholder, actual controller and other shareholders holding more than 5% of the voting shares of the company, other directors, supervisors and senior managers, and has not been subject to the circumstances that she is not allowed to serve as a director of the company as stipulated in the articles of Association of the CSRC, There are no circumstances specified in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, and there are no circumstances in which they are listed as dishonest Executees.
